Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER-positive/HER2-negative breast cancer
Aaron Mamann, Yoann Pradat, François‐Clément Bidard, Suzette Delaloge, Luc Cabel, Iris Faull, Sandrine Marques, Thomas Bachelot, Florence Dalenc, Thibault De La Motte Rouge, Barbara Pistilli, Johana Samaniego, Jean‐Sébastien Frenel, C. Levy, Jean Marc Ferrero, Robert Sabatier, Sylvain Ladoire, Camille Chakiba, A. Hardy, Jérôme Lemonnier, Younes Mahi, François André, Paul-Henry Cournède, Stefan Michiels, Elsa Bernard
Topics & Concepts
MedicineOncologyBreast cancerInternal medicineCirculating tumor DNACancerCancer researchCancer Genomics and DiagnosticsAdvanced Breast Cancer TherapiesBreast Cancer Treatment Studies